<DOC>
	<DOCNO>NCT00873639</DOCNO>
	<brief_summary>This trial conduct Europe . The aim observational study evaluate blood glucose control ( HbA1c ) use NovoRapid® ( insulin aspart ) Levemir® ( insulin detemir ) switch human insulins treatment type 1 diabetes normal clinical practice condition Romania .</brief_summary>
	<brief_title>Observational Study Type 1 Diabetics Switching From Human Insulins Modern Insulin Analogues</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Any subject type 1 diabetes treat human rapid intermediate ( NPH ) insulin basalbolus regimen Subjects currently treat insulin aspart insulin detemir Subjects previously enrol study Subjects hypersensitivity insulin aspart excipients Subjects hypersensitivity insulin detemir excipients Women pregnant intention become pregnant within next 6 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>